Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 21, 2018
Cobra Biologics and Symbiosis Pharmaceutical Services announced that they have been awarded a 16-month collaborative grant of £1.9m ($2.5m) from Innovate UK.
read more
Cobra Biologics and Symbiosis Pharmaceutical Services announced the successful completion of their collaboration to develop synergistic and world leading capabilities.
read more
Monday, February 13, 2012
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of three non-executive directors to Cobra Biologics’ board, and two business development managers tasked with driving ...
read more
Cobra Biologics has signed an agreement with AstraZeneca to manufacture the adenovirus vector-based COVID-19 vaccine candidate AZD1222.
read more
Wednesday, October 07, 2020
Cobra Biologics and Scancell Holdings have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine.
read more
Monday, February 06, 2017
Cocoon Biotech, Inc., is a biotechnology company focused on utilizing its silk protein-based drug delivery technology for the development of formulations to treat osteoarthritis and other conditions for which many patients find existing treatments to...
read more
Monday, February 11, 2019
Codexis announces a multi-year, exclusive supply agreement with KYORIN Pharmaceutical for the supply of a proprietary enzyme to be used in the manufacture of vibegron, an active ingredient in Beova Tablets, a novel, once-daily treatment for ...
read more
Thursday, January 15, 2026
Codexis and Axolabs, part of LGC Group, an oligonucleotide CRDMO, announced that they have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis Manufacturing Platform.
read more
Monday, February 25, 2019
Codexis announces the appointment of Laurie Heilmann to Senior Vice President of Business Development and Marketing.
read more
Codexis has announced the signing of a collaboration and license agreement with Takeda for the research and development of novel gene therapies for certain disease indications.
read more
Codexis and Alphazyme announced a Co-Marketing & Enzyme Supply Collaboration Agreement for the production and co-marketing of enzymes for life science applications.
read more
Codexis and Nestlé Health Science have signed an agreement to advance a lead candidate discovered through a SCA into preclinical development and early clinical studies.
read more
Wednesday, March 04, 2026
Codis announced a major expansion of its UK manufacturing capabilities with the purchase of a GEA Pharma-SD® type PSD-4 solvent-capable spray dryer. Codis will become the only UK CDMO offering this capacity. The addition will take place at its 400,...
read more
Tuesday, October 14, 2025
Codis, a newly established contract development and manufacturing organization (CDMO), has entered the pharmaceutical outsourcing market with a focus on commercial-scale spray drying and amorphous solid dispersion technologies.
read more
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more